Prashanthi Natarajan is an Associate Director of R&D at Natera, specializing in liquid biopsy and early cancer detection. With a PhD from the University of California, San Francisco, she has a track record of developing innovative oncology diagnostics, including significant contributions at both Natera and her previous role at Guardant Health.
She was a key contributor to Nateras Signatera assay, a paradigm-shifting technology for noninvasive cancer recurrence detection and therapy monitoring.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.